PURPOSE: This pilot study aimed to investigate the feasibility of two different training programs in patients with advanced gastrointestinal cancer undergoing palliative chemotherapy. Potential effects of training programs on the patients' quality of life, physical performance, physical activity in daily living, and biological parameters were exploratorily evaluated. METHODS: Patients were randomly assigned to a resistance (RET) and aerobic exercise training group (AET). Both underwent supervised training sessions twice a week for 12 weeks. RET was performed at 60-80% of the one-repetition maximum and consisted of 2-3 sets of 15-25 repetitions. The AET group performed endurance training at 60-80% of their predetermined pulse rate (for 10 to 30 min). RESULTS: A total of 26 gastrointestinal cancer patients could be randomized. Twenty-one patients completed the 12 weeks of intervention. The median adherence rate to exercise training of all 26 patients was 65%, while in patients who were able to complete 12 weeks, adherence was 75%. The fatigue score of all patients decreased from 66 to 43 post-intervention. Sleeping duration increased in both groups and muscular strength increased in the RET group. A higher number of steps in daily living was associated with higher levels of physical and social functioning as well as lower scores for pain and fatigue. CONCLUSION:RET and AET are feasible in gastrointestinal cancer patients undergoing palliative chemotherapy. Both training programs seem to improve cancer-related symptoms as well as the patient's physical activities of daily living.
RCT Entities:
PURPOSE: This pilot study aimed to investigate the feasibility of two different training programs in patients with advanced gastrointestinal cancer undergoing palliative chemotherapy. Potential effects of training programs on the patients' quality of life, physical performance, physical activity in daily living, and biological parameters were exploratorily evaluated. METHODS:Patients were randomly assigned to a resistance (RET) and aerobic exercise training group (AET). Both underwent supervised training sessions twice a week for 12 weeks. RET was performed at 60-80% of the one-repetition maximum and consisted of 2-3 sets of 15-25 repetitions. The AET group performed endurance training at 60-80% of their predetermined pulse rate (for 10 to 30 min). RESULTS: A total of 26 gastrointestinal cancerpatients could be randomized. Twenty-one patients completed the 12 weeks of intervention. The median adherence rate to exercise training of all 26 patients was 65%, while in patients who were able to complete 12 weeks, adherence was 75%. The fatigue score of all patients decreased from 66 to 43 post-intervention. Sleeping duration increased in both groups and muscular strength increased in the RET group. A higher number of steps in daily living was associated with higher levels of physical and social functioning as well as lower scores for pain and fatigue. CONCLUSION: RET and AET are feasible in gastrointestinal cancerpatients undergoing palliative chemotherapy. Both training programs seem to improve cancer-related symptoms as well as the patient's physical activities of daily living.
Authors: Jens Kelm; Frank Ahlhelm; Peter Weissenbach; Philipp Schliesing; Thilo Regitz; Gunther Deubel; Carsten Engel Journal: Arch Phys Med Rehabil Date: 2003-05 Impact factor: 3.966
Authors: Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charles S Fuchs Journal: J Clin Oncol Date: 2006-07-05 Impact factor: 44.544
Authors: Max Dahele; Richard J E Skipworth; Lucy Wall; Anne Voss; Tom Preston; Kenneth C H Fearon Journal: J Pain Symptom Manage Date: 2007-03-23 Impact factor: 3.612
Authors: R Crevenna; M Schmidinger; M Keilani; M Nuhr; V Fialka-Moser; G Zettinig; M Quittan Journal: Support Care Cancer Date: 2002-11-01 Impact factor: 3.603
Authors: Jeffrey A Meyerhardt; Shuji Ogino; Gregory J Kirkner; Andrew T Chan; Brian Wolpin; Kimmie Ng; Katsuhiko Nosho; Kaori Shima; Edward L Giovannucci; Massimo Loda; Charles S Fuchs Journal: Clin Cancer Res Date: 2009-09-01 Impact factor: 12.531
Authors: K S Courneya; C M Friedenreich; H A Quinney; A L A Fields; L W Jones; A S Fairey Journal: Eur J Cancer Care (Engl) Date: 2003-12 Impact factor: 2.520
Authors: Philipp Zimmer; Sina Trebing; Ursula Timmers-Trebing; Alexander Schenk; Rainer Paust; Wilhelm Bloch; Roland Rudolph; Fiona Streckmann; Freerk T Baumann Journal: Support Care Cancer Date: 2017-09-30 Impact factor: 3.603
Authors: J Frikkel; M Beckmann; N De Lazzari; M Götte; S Kasper; J Hense; M Schuler; M Teufel; M Tewes Journal: Support Care Cancer Date: 2021-02-19 Impact factor: 3.603
Authors: Nichola Gale; David Wasley; Sioned Roberts; Karianne Backx; Annemarie Nelson; Robert van Deursen; Anthony Byrne Journal: Support Care Cancer Date: 2018-06-02 Impact factor: 3.603
Authors: Marlies E W J Peters; Martine M Goedendorp; Constans A H H V M Verhagen; Gijs Bleijenberg; Winette T A van der Graaf Journal: Support Care Cancer Date: 2015-09-03 Impact factor: 3.603